Twin Lakes Capital Management, LLC Bio Atla, Inc. Transaction History
Twin Lakes Capital Management, LLC
- $150 Million
- Q3 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 10,500 shares of BCAB stock, worth $5,355. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,500
Previous 10,500
-0.0%
Holding current value
$5,355
Previous $14,000
28.57%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BCAB
# of Institutions
65Shares Held
17.4MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.36 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.28 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$961,4780.0% of portfolio
-
Morgan Stanley New York, NY1.86MShares$947,6690.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$445,7780.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $18.5M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...